Mirati Therapeutics, Inc. MRTX
Day range unavailable
52-week range unavailable
MRTX free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-575,421,000 USD
FY 2022 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | -575,421,000 | -176,826,000 | Not meaningful |
| FY 2021 | 2021-12-31 | -398,595,000 | -122,697,000 | Not meaningful |
| FY 2020 | 2020-12-31 | -275,898,000 | -126,620,000 | Not meaningful |
| FY 2019 | 2019-12-31 | -149,278,000 | -79,060,000 | Not meaningful |
| FY 2018 | 2018-12-31 | -70,218,000 | -5,431,000 | Not meaningful |
| FY 2017 | 2017-12-31 | -64,787,000 | 3,426,000 | Not meaningful |
| FY 2016 | 2016-12-31 | -68,213,000 | -17,170,000 | Not meaningful |
| FY 2015 | 2015-12-31 | -51,043,000 | -17,909,000 | Not meaningful |
| FY 2014 | 2014-12-31 | -33,134,000 | -3,479,000 | Not meaningful |
| FY 2013 | 2013-12-31 | -29,655,000 | -12,775,000 | Not meaningful |
| FY 2012 | 2012-12-31 | -16,880,000 | -5,203,000 | Not meaningful |
| FY 2011 | 2011-12-31 | -11,677,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:14.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.